Literature DB >> 9349322

Splenomegaly as the first manifestation of thyroid cancer metastases.

R Paolini1, S Toffoli, A Poletti, D Casara, P Moschino, F Fabris, A Girolami.   

Abstract

We report the case of a 65-year-old man who developed a symptomatic splenomegaly due to spleen metastasis from thyroid follicular carcinoma. In 1982, at the age of 53, the patient had undergone a thyroid lobectomy for a cold node, followed one year later by a second intervention for a microfollicular adenoma. He was subsequently administered thyroid suppressive therapy with no further follow-up. The diagnosis of spleen metastases from thyroid cancer was first suspected on the basis of history, high serum thyroglobulin (Tg) levels, and the presence of pulmonary 99Tc uptake. The patient underwent a splenectomy, during which vast infiltration involving the diaphragm, spleen, stomach, colon and pancreas, was found. Histological and immunohistochemical results showed that the spleen and diaphragm metastases derived from thyroid follicular carcinoma. Radioiodine uptake by the pulmonary metastases confirmed the thyroid source. Retrospective re-evaluation of the thyroid tissue removed in 1983 revealed a histological pattern consistent with follicular carcinoma, which could not be unequivocally attributed to the widely or minimally invasive form. To our knowledge this is the first report of splenomegaly as the first manifestation of thyroid cancer metastases. In this paper cases of splenomegaly due to metastatic spread are reviewed and the management of the present case is discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9349322     DOI: 10.1177/030089169708300414

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  5 in total

1.  Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraft.

Authors:  Manoj Garg; Ryoko Okamoto; Yasunobu Nagata; Deepika Kanojia; Subhashree Venkatesan; Anand M T; Glenn D Braunstein; Jonathan W Said; Ngan B Doan; Quoc Ho; Tadayuki Akagi; Sigal Gery; Li-Zhen Liu; Kar Tong Tan; Wee Joo Chng; Henry Yang; Seishi Ogawa; H Phillip Koeffler
Journal:  J Clin Endocrinol Metab       Date:  2014-11-03       Impact factor: 5.958

2.  Metastatic involvement of the spleen in differentiated carcinoma of thyroid.

Authors:  Purushottam Kand; Ramesh Asopa
Journal:  Indian J Nucl Med       Date:  2010-10

Review 3.  Splenectomy for non-haematological metastatic malignant disease.

Authors:  Piers A C Gatenby; Satvinder S Mudan; Andrew C Wotherspoon
Journal:  Langenbecks Arch Surg       Date:  2011-02-17       Impact factor: 3.445

4.  Splenectomy for Solitary Splenic Metastasis in Recurrent Papillary Thyroid Cancer. A Case Report and Literature Review.

Authors:  Antonio Maffuz-Aziz; Gabriel Garnica; Silvia López-Hernández; Janet Pineda-Diaz; Javier Baquera-Heredia; Patricia López-Jiménez
Journal:  Case Rep Oncol Med       Date:  2020-05-04

Review 5.  Polysplenia Syndrome With Splenic and Skeletal Muscle Metastases From Thyroid Carcinoma Evaluated by FDG PET/CT: Case Report and Literature Review: A Care-Compliant Article.

Authors:  Zu-Gui Li; Zhi-Chun Lin; Hai-Yu Mu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.